-
This influenza immunization season may be one of the most challenging for the nation's hospitals as they face a new requirement to track every employee, licensed practitioner, student and volunteer.
-
As the nation faces the largest outbreak of pertussis in 50 years, the rate of vaccination of health care workers languishes at about 20%.
-
Conceding that the effectiveness of risk-based hepatitis C virus testing has plateaued, public health officials are rolling the dashboard dice to capture the grand-daddy of all birth cohorts: Baby Boomers.
-
-
In this issue: Dementia and benzodiazepines; effectiveness of omega-3 fatty acid and Ginkgo biloba supplements; and FDA actions.
-
-
Recurrent C. difficile infection (CDI) is a challenging condition to manage. Current guidelines estimate that 25% of patients treated for CDI experience at least 1 additional episode, with those aged 65 years or greater at highest risk.
-
Sanofi Pasteur announced September 28, 2012 a recall of 6 lots of Typhim Vi polysaccharide vaccine, the injectable "killed" vaccine. A significant portion of the stock has been shown to be insufficiently immunogenic and at risk for "low antigen content."
-
An investigation initiated after a clinician reported to the Tennessee Department of Health on September 18, 2012 the case of a patient who developed meningitis due to Aspergillus fumigatus after having received an epidural corticosteroid injection at an ambulatory surgical center quickly identified a number of other suspect cases.
-
At Duke University Health System, a tertiary-care medical center that has traditionally provided aggregated antimicrobial susceptibility data from both adult and pediatric isolates, antibiograms for Escherichia coli isolates from children ¡Ü12 years of age from July 2009 to September 2010 were developed and compared with antibiograms that combined adult and pediatric data. A total of 375 pediatric isolates were obtained from 327 patients.
